DREAM trains exceptional pre-docs, post-docs, and assistant professors who are committed to health equity research.

With this move, UK HealthCare reinforces a commitment to clinical research and exceptional patient care.

Deadline is Oct. 4, 2024.

UK ASCEND is supported by a nearly $3 million grant from the National Institute on Minority Health and Health Disparities.

LEXINGTON, Ky. (Aug.

Morgan Jones, MD, will use the award to inform the design of a pilot trial centered on breast cancer. Her specific interests are in triple-negative breast cancer, disparities in treatment outcomes, and tumor microenvironments.

LEXINGTON, Ky. (Aug. 7, 2024) – Despite the prevalence and toll of late-onset Alzheimer’s disease—the most common type, which begins after age 65— causes of the disease remain only partly understood.  Is it genes? Lifestyle? Environment?

This episode of "Behind the Blue" podcast delves into Hartmann's research and her goals for the center.

He is acting chair and professor in the Department of Biostatistics in the University of Kentucky College of Public Health and a member of the CCTS Biostatistics, Epidemiology and Research Design Core.

He serves as director of the Center for Pharmaceutical Research and Innovation (CPRI) and co-director of the Center for Clinical and Translational Science (CCTS) Drug Discovery and Development Core